Shin-Etsu, 24/3 operating profit down 29.8% to 701 billion yen

In the financial results for the fiscal year ending 2024/3 announced by Shin-Etsu Ka ＜4063＞, sales were 2,414.937 billion yen, down 14% from the previous fiscal year, and operating profit was 701,038 billion yen, down 29.8% from the same period. In the electronic materials business, the semiconductor market continued to adjust in the fall of the year before last, even in this period, but signs of bottoming out appeared. In the processing/trading/technical service business, demand for semiconductor wafer-related containers continued to be adjusted mainly for in-process use, but automotive input devices were recovering in response to a recovery in the automotive industry

Fisco Japan16:25 ET

Check out the disclosed information for [Tomorrow's Good and Bad Materials]! (Announced on 4/25)

<1770>[Good Material] ――――――――――■Fujita Engineering [TSE S] reversed the previous fiscal year's account upward to a 23% increase in profit · highest profit for the first time in 6 fiscal years, and dividends also increased by 20 yen. ■Yurtech <1934>[Tokyo Stock Exchange P] Current fiscal year profit increased 8%, previous fiscal year dividend increased by 12 yen, current fiscal year dividend increased by 4 yen. ■Meisei Kogyo <1976>[Tokyo Stock Exchange P] reversing the previous fiscal year's earnings upward to 17% increase · highest profit for the first time in 5 fiscal years, and dividends also increased by 19 yen. ■MONOTARO <3064>

MinkabuApr 25 07:09 ET

Astellas Pharma Annual Net Plunges, But Revenue Climbs; Expects 2024 Result To Improve

RTTNewsApr 25 06:51 ET

Pursue high-growth companies! Fiscal Year Ending 25/3 [Increase in Sales and Profit] List ＜Special Feature on Growth Stocks＞ 4/25 Edition

As financial results announcements for the fiscal year ending March 31, '24 are in full swing, market attention is focused on the earnings forecast for the fiscal year ending 25/3, which will be announced at the same time. Demand for semiconductors is expected to recover this fiscal year, and it seems that there are many views that the upward trend in profit will continue, as domestic demand-related expansion is also expected against the backdrop of the penetration of price increases and an increase in inbound consumption due to depreciation of the yen. There is also growing interest in movements to strengthen shareholder returns aimed at improving capital efficiency.

MinkabuApr 25 06:00 ET

Astellas made an upward move at the end of the previous fiscal year; profit increased 76% and dividends increased by 4 yen this fiscal year

Astellas Pharma [Tokyo Stock Exchange P] announced financial results (International Accounting Standards = IFRS) after closing on 4/25 (15:00). Consolidated final profit for the fiscal year ended March 24 fell 82.7% from the previous fiscal year to 17 billion yen, but it surpassed the previous forecast of 3 billion yen and landed. The fiscal year ending 25/3 is expected to recover to 30 billion yen, an increase of 76.0% from the previous fiscal year. Sales will increase for 4 consecutive terms. At the same time, the policy was to increase the annual dividend for the current fiscal year to 74 yen, an increase of 4 yen from the previous fiscal year.

MinkabuApr 25 02:01 ET · Earnings

Astellas Pharma FY Oper Pft Y25.52B Vs Pft Y133.03B

Astellas Pharma FY Oper Pft Y25.52B Vs Pft Y133.03B

Dow JonesApr 25 02:00 ET